Reimagined Drug Discovery
Our mission is to create a new class of medicines with AI and spatial biology.
Based on best-in-class, computer vision/AI software developed by Caltech Professor Dr. David Van Valen, Barrier.bio is developing medicines to cross and modulate biological barriers. The company is backed by leading venture capital investors and headquartered in Southern California.
Based on best-in-class, computer vision/AI software developed by Caltech Professor Dr. David Van Valen, Barrier.bio is developing medicines to cross and modulate biological barriers. The company is backed by leading venture capital investors and headquartered in Southern California.